Showing results (231-240 of 295) with videos related to
Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2019
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE StudyRina Hui, Alex Pearson, Javier Cortes, et al.British Journal of Cancer|July 23, 2013
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)S Sahebjam, P L Bedard, V Castonguay, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2024
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatmentJoanna Baginska, Allison Nau, Ilana Gomez Diaz, et al.Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.Nature Genetics|August 30, 2016
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancerSwneke D Bailey, Kinjal Desai, Ken J Kron, et al.Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2024
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast CancerKomal L Jhaveri, Melissa K Accordino, Philippe L Bedard, et al.Journal for Immunotherapy of Cancer|June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumabGeoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.ACS Combinatorial Science|November 13, 2015
Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin ReceptorZining Wu, Todd L Graybill, Xin Zeng, et al.Cancer Research Communications|February 8, 2024
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer RegistryEnrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, et al.Pageof 30